Maxcyte (MXCT) Other Non-Current Liabilities (2020 - 2026)

Maxcyte (MXCT) has reported Other Non-Current Liabilities for 7 consecutive years, with $302000.0 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Other Non-Current Liabilities rose 21.77% year-over-year to $302000.0 in Q2 2026; TTM through Jun 2026 was $302000.0, a 21.77% increase from a year earlier, with the FY2025 full-year figure at $263000.0, down 4.01% from the prior year.
• Other Non-Current Liabilities was $302000.0 for Q2 2026 at Maxcyte, up from $262000.0 in the prior quarter.
• Over five years, Other Non-Current Liabilities peaked at $1.3 million in Q4 2022 and troughed at $227000.0 in Q3 2025.
• A 5-year average of $534994.1 and a median of $283000.0 in 2023 frame the typical range for Other Non-Current Liabilities.
• Across the five-year window, Other Non-Current Liabilities soared 232.93% in 2023 and plunged 78.99% in 2024, its largest moves.
• Over 5 years, Other Non-Current Liabilities stood at $1.3 million in 2022, then slumped by 78.56% to $283000.0 in 2023, then dropped by 3.18% to $274000.0 in 2024, then decreased by 4.01% to $263000.0 in 2025, then rose by 14.83% to $302000.0 in 2026.
• The last three Other Non-Current Liabilities figures came in at $302000.0 (Q2 2026), $262000.0 (Q1 2026), and $263000.0 (Q4 2025), per Business Quant data.